Furthermore, SHIP2 is a positive regulator of the epidermal growth factor receptor/Akt pathway, C-X-C chemokine receptor type 4 expression, and cell migration in MDA-MB-231 breast cancer cells [67]. This evidence concerns the gene CXCR4 and breast carcinoma.